ASELL

What ASELL does

ASELL, LLC is a privately held Maryland-based medical device and consulting firm founded in 2017 and headquartered in Owings Mills. The company develops two proprietary biodosimetry diagnostic systems — CellRADx™, a point-of-care triage system using hematological data and biodosimetry algorithms for early radiation exposure assessment, and CytoRADx™, a high-throughput confirmatory system that automates the IAEA-accepted Cytokinesis Block Micronucleus (CBMN) assay. CellRADx was developed in collaboration with the Armed Forces Radiobiology Research Institute (AFRRI), while CytoRADx development has been funded by the Biomedical Advanced Research and Development Authority (BARDA) to address mass-casualty radiological/nuclear response and is undergoing validation studies for FDA authorization.

The company's commercial model combines two revenue streams. The first is a professional and managed services business spanning regulatory affairs (FDA submissions, EUA support), quality management system development, clinical research (Phase I–III, IRB submissions, data analysis), product development, and government contracting pursued through federal channels. The second is a product business tied to the CellRADx and CytoRADx diagnostic platforms, with distribution targeted at laboratories and emergency response facilities. Go-to-market is direct enterprise engagement with government agencies (AFRRI, BARDA) and medical device developers; marketing channels include an Insights blog, conference participation at events such as MHSRS and the Radiation Research Society Annual Meeting, and direct website inquiries.

ASELL is founder-owned, with leadership drawn heavily from Northrop Grumman's CBRNE defense business, supplemented by former FDA in vitro diagnostics reviewers and IVD industry veterans from Cylex, MRIGlobal, Becton Dickinson, and Guardant Health. The company maintains a broad partner/technology ecosystem (MetaSystems, NeoGenomics, Thermo Fisher, Alentic, Hotgen, Inivata, Gator Bio, Zymo Research, and others) suggesting light-touch integrations across the diagnostics workflow. No pricing is publicly disclosed, and revenue figures are not available in the input material.

Name

ASELL

Legal name

ASELL, LLC

Website

https://asell.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

ASELL is a privately held Maryland-based medical device company developing biodosimetry diagnostic systems (CellRADx and CytoRADx) for radiation emergency preparedness and providing regulatory, quality, clinical research, and government contracting services to medical device developers and federal agencies.

Ownership category

akta.pro rank

Headquarters

HQ city

Owings Mills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Regulatory Affairs Services: Provides regulatory strategy development, FDA submission preparation, Emergency Use Authorization support, and regulatory compliance consulting for medical device companies.
2. Quality Management Services: Quality Management System development, implementation, training, and audit support services for medical device companies.
3. Clinical Research Services: Clinical study project management, protocol development, IRB submissions, site management, data analysis, and clinical performance testing services.
4. Government Contracting: Pursues and executes federally-funded programs supporting medical device development and emergency preparedness technologies.
5. Biodosimetry Diagnostic Products: Development and potential commercialization of CellRADx and CytoRADx biodosimetry diagnostic systems for emergency preparedness applications.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

ASELL develops and delivers biodosimetry diagnostic products (CellRADx™ triage system and CytoRADx™ confirmatory system) for radiation emergency preparedness, and provides professional services spanning regulatory affairs support, quality management, clinical research, product development, and government contracting for medical device developers and federal agencies. The company advances technologies from early-stage development through product delivery, with deep expertise in CBRNE defense, in vitro diagnostics, and FDA regulatory pathways.

Product overview

ASELL is a medical device and diagnostic company that develops and delivers cutting-edge technology solutions for health security and emergency preparedness. The company's product portfolio consists of two distinct biodosimetry diagnostic systems: CellRADx™ for rapid triage biodosimetry and CytoRADx™ for confirmatory biodosimetry testing. CellRADx provides point-of-care triage capabilities using hematological data and algorithms to identify individuals needing acute medical care following radiation exposure, while CytoRADx offers high-throughput laboratory-based confirmatory testing using an automated Cytokinesis Block Micronucleus (CBMN) assay. Together, these products are designed to enhance national preparedness for mass-casualty radiological or nuclear events by enabling rapid patient triaging and quantitative exposure characterization.

Differentiator

Problem solved

Functional benefit

Brands

• CellRADx™: Triage Biodosimetry system developed in collaboration with AFRRI (Armed Forces Radiobiology Research Institute). Uses hematological data and biodosimetry algorithms to provide early diagnostic information for radiation exposure triage.
• CytoRADx™

Products and services

• CellRADx™ – Triage Biodosimetry

Quantifiable outcome

• High-throughput capability to test hundreds of thousands of people following a radiological incident
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Armed Forces Radiobiology Research Institute (AFRRI)coreStrategic or Co-development PartnerASELL is collaborating with AFRRI to develop the CellRADx biodosimetry system for point-of-care radiation dose assessment and triage. AFRRI provides scientific expertise and the collaboration enables development of diagnostic tools for military and civilian emergency response applications.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Battelle Memorial Institute: Large non-profit applied science organization with deep CBRNE defense, medical countermeasure, and government health R&D programs. Comparable to ASELL in mission focus (national security / health security), federal contracting model, and biodosimetry/biodefense capabilities.
• Mirion Technologies: Public company specializing in radiation detection, dosimetry services, and nuclear measurement solutions serving defense, medical, and industrial markets. Comparable to ASELL in serving the radiological/nuclear preparedness buyer base, with overlapping biodosimetry and radiation-exposure assessment capabilities.
• SRI International: Non-profit R&D organization with biosciences and medical device programs, including CBRNE-related work for government sponsors. Comparable to ASELL in combining federal contract R&D services with diagnostic/biomedical technology development for defense and public health customers.
• MRIGlobal: Independent, non-profit applied research organization with a long track record in CBRNE defense, biodosimetry method development, and federal contract execution. Highly comparable to ASELL on government biodefense R&D services and diagnostic assay development, and ASELL's Senior Director of Business Development (Michael Ehret) previously served as SVP there.
• NAMSA: Contract research organization providing medical device regulatory, quality, and clinical research services to IVD and medical device developers. Highly comparable to ASELL's services arm (regulatory affairs, QA, clinical research) and overlapping client base of medical device and IVD sponsors.

Broad incumbents

• Leidos: Large federal systems integrator and life sciences contractor with significant health and biodefense portfolios serving DoD, BARDA, and HHS. Comparable to ASELL on the government health/biodefense contracting axis, but at vastly larger scale and broader scope than ASELL's niche biodosimetry focus.
• Landauer (Fortive): Established provider of radiation dosimetry monitoring services and products for medical, occupational, and defense markets. Comparable to ASELL in serving radiation-exposure assessment use cases, but with a much larger installed base in occupational and clinical dosimetry rather than mass-casualty biodosimetry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ASELL_LLC
• LinkedInlinkedin.com/company/asell

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ASELL